troke is a leading cause of death and disability worldwide. 1 A significant proportion of this disability is because of poststroke neurocognitive disorders (PSNCDs), 1 which include mild cognitive impairment and dementia. PSNCDs affect half of stroke victims, with mild cognitive impairment representing about two-thirds and dementia, about one-third of PSNCDs.
having been largely emphasized on clinical grounds. 10 Most of the above-mentioned studies presented 3 main limitations. First, the studies focused on dementia 11 rather than the more frequent mild cognitive impairment. Second, most studies examined the association between PSNCD and various determinants without evaluating their relative contributions. Third, most studies were based on a mass-effect approach (ie, gross quantitative measures, such as the stroke volume and global white matter scores), which precluded any conclusions on the contribution of precise stroke locations and patterns (eg, strategic lesions). Hence, we aimed to define neuroimaging determinants of poststroke global cognitive performance in a large, prospective cohort of patients with stroke. To improve the determination of structure-function relationship, we used a standardized optimized global cognitive score (GCS) and combined both quantitative measures related to structure loss (brain, hippocampal, and lesion volumes) and qualitative measures related to the presence of strategic lesion as determined using a specifically designed method.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Design, Setting, and Population
Between September 2010 and November 2016, 358 patients had been prospectively included in the multicenter GRECogVASC (Groupe de Réflexion pour l'Évaluation Cognitive Vasculaire) study (NCT01339195). Details of the study protocol have been previously reported. 12 Briefly, all consenting French-speaking patients aged between 40 and 80 years, hospitalized for acute (<30 days) cerebral infarct or hemorrhage with initial positive imaging, a reliable informant, and no previously diagnosed conditions affecting cognition (except for previous stroke) were included (see the online-only Data Supplement for the exclusion criteria). Clinical, neuropsychological, and MRI examination was performed at the 6-month visit. The study was performed in accordance with institutional guidelines and was approved by the regional investigational review board (Comité de Protection de Personnes Nord-Ouest II, Amiens, France; reference: 2010/25).
Data Assessments

Clinical Variables
Standard demographic characteristics, the main vascular risk factors, previous transient ischemic attack or stroke (ischemic and hemorrhagic), current stroke characteristics (ischemic and hemorrhagic, location, pathogenesis [with the TOAST classification (Trial of ORG 10172 in Acute Stroke Treatment) for ischemic stroke]), and disability (on the National Institutes of Health Stroke Scale and the modified Rankin Scale 13 ) were prospectively recorded for each patient.
Neuropsychological Assessment: The Optimized GCS
Methods and prevalence of cognitive impairment had already been reported. 2 Each patient performed the full GRECogVASC neuropsychological battery, using the French adaptation of the Harmonization Standards battery 12 (see the online-only Data Supplement). The results of each test were analyzed using a validated framework for the interpretation of normative cognitive data 14 from 1003 healthy volunteers according to a previously reported methods 15 16 We used an optimized GCS as marker of cognitive performance. As previously reported, 2 The GCS corresponds to the standardized residuals of 3 cognitive domain scores (language, executive functions, and action speed) after adjustment for significant demographic factors (age, sex, and educational level). This score combining the scores of the 3 most sensitive domains was previously found to discriminate PSNCDs with both high specificity and sensitivity.
2 Structural Brain MRI, Acquisition, and Interpretation MRI scans were obtained 6 months poststroke, on a 3-T machine (SIGNA HDxt, General Electric Medical Systems) equipped with an 8-channel head coil (see the online-only Data Supplement for details of data acquisition) and the following analyses were performed: (1) stroke lesions: the presence, type, number, and volume of cerebral infarcts and hemorrhages were evaluated using the 3-dimensional (3D)-T1 BRAVO sequence and the STandards for ReportIng Vascular changes on nEuroimaging criteria 17 and a previously validated method. 18 Stroke lesion was defined as cavitation with a diameter >4 mm, and no arguments for other causes of cavitation (especially perivascular dilatation). 18 Lesions were defined by reference to the initial poststroke MRI and especially the diffusion-weighted imaging and T2* sequences. Multiple stroke lesions were defined as lesions that did not coalesce on at least one slice, whatever their age. Trained investigators manually segmented the lesions on native 3D-T1 MRI data sets using Mricron. The lesion masks were normalized using a template for older individuals 19 using Statistical Parametric Mapping 12 (SPM12) software (http://www.fil.ion.ucl.ac.uk/spm/software/ spm12/). All brain normalizations were validated with a visual quality check. Normalized lesion masks were used to compute the stroke volume that took into account all strokes, including recurrent stroke.
(2) Markers of small vessel disease: WMH and microbleeds were identified according to the STandards for ReportIng Vascular changes on nEuroimaging criteria. 17 The WMH burden was assessed using the Fazekas score 20 on the basis of the fluid-attenuated inversion recovery sequence. Brain microbleeds were defined as small (<10 mm in diameter) areas of signal void with associated blooming seen on T2*-weighted MRI, according to the brain observer microbleed scale criteria. 21 T2 sequence was used to assess the presence of dilated perivascular spaces.
(3) Medial temporal lobe atrophy: medial temporal lobe atrophy on each side of the brain was evaluated on the Scheltens score 22 using 3D-T1 coronal sequences (total score=left+right hippocampal score).
(4) Global cerebral atrophy: brain tissue volumes (normalized for the subject's head size) were determined on 3D-T1-weighted images with the fully automated, segmentation-based Structural Image Evaluation using Normalization of Atrophy algorithm (part of the FMRIB Software Library). 23 Structural Image Evaluation using Normalization of Atrophy starts by extracting brain and skull images from the whole-head input data. The brain image is then affine-registered in MNI152 space by using the skull image to determine the registration scaling and skew; this gives the volumetric scaling factor to be used for head size normalization. Next, tissue-type segmentation with partial volume estimation is used to calculate the total normalized brain volume (including separate estimates of gray matter and white matter).
(5) Strategic strokes: Strategic strokes were defined as small lesions (defined as a stroke volume below the first tertile, ie, volume ≤366 mm 3 ) associated with cognitive impairment in the absence of cerebral atrophy (defined as brain volume above the first tertile, ie, a volume ≥13 900 cm 3 ). The initial selection of patients without atrophy was done to exclude cognitive impairment related to other process, especially Alzheimer disease. The lesions were determined in 4 steps. First, the strategic sites were initially sketched out by overlapping the masks of small lesions associated with cognitive impairment (n=42), using Mricron. Second, the locations of strategic sites were determined using Automatic Anatomical Labelling and NatbrainLab templates. These sites include small foci within the following regions: the anterior and middle parts of the left and right thalami, the left and right corticospinal tracts, the left posterior-inferior (crus 8) and posterior-middle (crus 1) parts of the cerebellar hemisphere, the lateral bulbar regions, pons, left middle occipital region, left middle frontal gyrus, left arcuate fasciculus, and many foci <50 mm 3 in the right hemisphere (the striatum, inferior longitudinal fasciculus, and
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November 2018 optic radiations). Importantly, only 4 patients with a lesion in at least one of these sites had another lesion (including 3 patients with the second lesion in another strategic site and 1 patient with a lesion in the striatum). Interestingly, damage to postero-inferior cerebellum was not associated with supratentorial lesions. Third, the impact of each strategic site lesion on the GCS in the full study population was examined with a Mann-Whitney U test. The main results are summarized in Figure 1 . Only sites with a P<0.2 were fed into the subsequent regression analysis. Fourth, we controlled for the effect of multicollinearity: a lesion at 1 site may sometimes be selected not because it is causally related to cognitive impairment per se but because it is frequently associated with another lesion that is causally related to cognitive impairment. 18 This check was performed with a multivariable stepwise linear regression analysis of all patients, using the GCS as the dependent variable and the presence of a lesion at each of the above-mentioned strategic sites as the independent variable. The strategic strokes variable indicates the presence or absence of a lesion at one or more of these strategic sites, regardless of the lesion volume.
Statistical Analysis
Continuous, ordinal, and categorical variables were expressed as the mean±SD, the median (interquartile range), or the number (percentage), respectively. Data were log-transformed as appropriate. Each patient's performance was analyzed with regard to a validated framework for the interpretation of normative cognitive data (n=1003 controls). The standardized residuals of cognitive scores used to compute the GCS (language, action speed, and executive function) were adjusted for significant demographic factors: age, sex, and educational level. We calculated with a simple linear regression R 2 and P values to identify MRI markers related with the GCS in a univariate analysis. The independent variables were the following MRI markers: side of the damaged hemisphere, multiple strokes, recurrent stroke, stroke volume, type of stroke (ischemic or hemorrhagic), presence of a strategic stroke, total normalized brain tissue volume, medial temporal lobar atrophy, WMH burden, brain microbleeds, and presence of dilated perivascular spaces. A multiple linear regression analysis was used to determine independent correlates of cognitive performance (as assessed by the GCS). All variables with a P<0.2 in univariate analysis were fed into the multivariate one. Multicollinearity was ruled out by applying standard procedures. A stepwise selection procedure was used to optimize the model's fit and to determine the proportion of the variance in cognitive performance accounted for by each correlate. Estimates, SEs, and standardized β coefficients were calculated so that the correlates could be compared. All statistical analyses were performed using SPSS software. The threshold for statistical significance level was set to P<0.05.
Results
For 2 patients, poor-quality 3D-T1 MRI data prevented reliable normalization. Hence, the final analysis was performed on data from the 356 remaining patients. Characteristics of our hospital-based stroke cohort are reported in Table 1 . Briefly, mean age was 63.67±10.6 years, and 60.7% (n=216) were male. Two hundred patients (56.2%) had an modified Rankin Scale score ≥2. Most of the patients (n=326; 91.6%) presented with ischemic stroke, and 7 patients (2%) had experienced a recurrent ischemic stroke between inclusion and the 6-month evaluation. Only 1 patient experienced from prestroke dementia because of a previous stroke. The prevalence of 6-month PSNCD was 50.8%. In the univariate analysis (Table 2) , the factors related to the GCS with P<0.2 included previous stroke, stroke volume, multiple strokes, ischemic stroke, a lesion in the left hemisphere, strategic strokes, total normalized brain tissue volume, total medial temporal lobe atrophy, WMH burden, and the presence of microbleeds. These factors were fed into the regression analysis. Stepwise linear regression selected 4 factors that were independently associated with the GCS: the presence of a strategic stroke, total medial temporal lobe atrophy, total normalized brain tissue volume, and stroke volume (Table 3) . Strategic strokes accounted for 22.5% of the variance in the GCS while total medial temporal lobe atrophy, stroke volume, and total normalized brain volume together accounted for an additional 11.8% (Table 3) . Assessments of a possible threshold effect for WMH burden and the number of microbleeds did not change the main findings (data not shown). The relationship between GCS and lesion volume by brain volume tertile is represented in Figure 2 . This figure also illustrates the key role of strategic strokes, which accounted for low cognitive performance in patients with both a small stroke volume and no cerebral atrophy. The same analyses were performed using a GCS combining all 5 cognitive domains (language, visuoconstructive abilities, memory, executive functions, and action speed) and provided similar findings (see the onlineonly Data Supplement).
Discussion
The major findings of this prospective, hospital-based study of poststroke patients (half of whom presented with cognitive impairment) are that (1) of the many different MRI markers, the presence of a lesion within small strategic sites (the right corticospinal tract, left antero-middle thalamus, left arcuate fasciculus, left middle frontal gyrus, or left postero-inferior cerebellum) was the main determinant of poststroke cognitive *A score below the fifth percentile of the global cognitive score was considered to correspond to impairment.
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November 2018 performance and accounted for 22.5% of the observed variance in the GCS; (2) stroke volume, total medial temporal lobe atrophy, and brain tissue volume were independent but weaker determinants, and (3) the WMH burden and the presence of microbleeds were not independent role determinants. The total stroke volume accounted for only a small proportion (4.3%) of the variability in cognitive performance in stroke patients. This finding emphasizes the fact that lesions in strategic areas have a key role in the occurrence of PSNCDs regardless of their volume. One of the strengths of our study was its combination of a mass-effect approach (as indexed by lesion and brain volumes) with a specifically determined strategic lesion approach. Although many strategic sites have been proposed on clinical grounds (ie, the thalamus, angular gyrus, and the basal ganglia, including the caudate nucleus and globus pallidus), 10 we systematically defined strategic locations using a specifically designed methods and integrated them into the spectrum of MRI markers. The cognitive impact of small lesions in the antero-middle part of the thalamus is well documented, 24 and we expected this structure to be selected as a strategic stroke. The left middle frontal gyrus is critically associated with language, 25 executive function, 26 and action speed. 27 The left arcuate fasciculus has a particular role in language. 25, 28 The consequences of damage to the corticospinal tract or the cerebellum are usually considered to be restricted to motor and sensory domains; however, it is likely to influence action speed 29 that is one of the components of the GCS. The prominent role of right corticospinal tract is likely to be because of its tightest relationship with action speed, and this is highly consistent with the right hemisphere prominence for action speed as previously documented. 30 The cognitive consequences of cerebellar stroke are subject to debate. 31 The crus 8 area is reportedly associated with cerebellar cognitive affective syndrome, 32 and our results support this finding. The associations between strategic site and cognitive domains and the lesions' effects on cognitive networks warrant further investigation that are outside the scope of the present study.
Overall, atrophy is one of the most controversial MRI markers with regard to the influence on poststroke cognitive performance. 3, 33, 34 Our data indicate that cerebral atrophy (as assessed with a robust, fully automated algorithm) is associated with impairments in poststroke cognitive performance. Although the pathophysiological mechanisms of poststroke brain atrophy have not been fully elucidated, postischemia neurodegeneration in the subcortical region is probably one of the main contributors. 35 Our results also emphasize the role of medial temporal lobe atrophy in PSNCD, 9 independently from a potentially associated Alzheimer disease. Medial temporal lobe atrophy may be related to delayed ischemic injury in hippocampal areas associated with selective vulnerability in a pure vascular process. The putative contributions of associated Alzheimer disease and amyloid angiopathy are currently being examined in an ancillary amyloid positron emission tomography study (IDEA3 [Cerebral Amyloid Imaging Using Florbetapir (AV-45) for the Etiological Diagnosis of Poststroke Cognitive Impairment and Dementia]; NCT02813434). Brain microbleeds and the WMH burden were found to have a weak association with cognitive performance, and these factors were only statistically significant in univariate analyses. We did not find any evidence of a threshold effect for the WMH burden or the number of microbleeds. These findings indicate that (1) WMH and brain microbleeds make only small contributions to PSNCDs in the stroke population and (2) stroke lesions might override the effect of WMH. In further research, we intend to examine the influence of the microbleeds location and the presence of hemosiderosis.
Even if the GCS did not take into account long-term memory and visuoconstructive abilities, it had been previously showed to discriminate at best poststroke cognitive impairment. 2 In addition, the use of a full GCS incorporating long-term memory and visuoconstructive abilities performance provided similar results (see the online-only Data Supplement for the statistical results).
Our study had some limitations. First, the recruitment time period was relatively long and included a reorganization of our medical center in 2014 that was associated with an increase in the thrombolysis rate. 36 However, we did not observe any effects of cerebral reperfusion in a previous study.
2 Second, the cross-sectional design prevented us from investigating the relationship between MRI markers and long-term cognitive performance. This aspect will be addressed in the ongoing ancillary IDEA3 study. Third, it is not known whether the Structural Image Evaluation using Normalization of Atrophy method can be applied reliably to patients with widespread stroke damage. Hence, there is a risk of imprecision in the measurement of normalized brain volume in these patients. However, each acquisition was visually checked by experienced operators, and inaccurate measurements would have decreased the strength of the relationship with cognitive performance. Fourth, we chose to study both cerebral infarcts, hemorrhage, and all causes of stroke (large and small infarcts, and lobar and deep hemorrhages), so that our study cohort was representative of clinical populations. This choice prevented us from specifically analyzing stroke subtypes, such as lobar hemorrhage. However, this design has the advantage of reducing multicollinearity 37 and evidencing stroke-related factors for all subtypes. Furthermore, our results were essentially unchanged (data not shown) after cases of intracerebral hemorrhage were removed from the analysis. Fifth, each strategic site's contribution to the various cognitive domains will require further analysis. However, our novel method for the determination of strategic strokes will be useful for application in future research. Sixth, we did not differentiate between lobar and deep microhemorrhages even though these entities are associated with differently frequencies of dementia. 38 Furthermore, we did not assess cortical microinfarcts, which might be an independent risk factor for cognitive impairment. 39 However, microinfarcts are more prevalent in older populations and are associated with cerebral atrophy assessed in the present study. Both factors will be analyzed in the ancillary IDEA3 study. Seventh, the present cohort was characterized by a younger age and lower severity as compared with population-based stroke studies. 40 The absence of patients with modified Rankin Scale score >4 is explained by the fact that a large majority of these patients did not attend the inclusion visit performed at the 6-month visit and that included cognitive assessment. However, the present study was designed to focus on cognitive outcome in patients with modified Rankin Scale score <5. Demographic characteristics may affect the prevalence and mechanisms of cognitive deficit, with higher prevalence of Alzheimer disease in the oldest patients. However, the under-representation of older patients is unlikely to have affected our main findings as our imaging determinants took into account characteristics related to both vascular and degenerative lesions. Elsewhere, we acknowledge that the size effect of each determinant would changes in stroke population with a higher frequency of elderly and severe strokes. External validation is required for the generalization of our results to all patients with stroke.
Our study also had many strengths. The large sample size enabled us to define many strategic sites and feed many factors into the regression model. Our study offers an original and accurate approach using an optimized GCS and a specifically designed method to model the structure-function relationship of poststroke cognitive performance. We analyzed most of the likely radiological determinants of poststroke cognitive performance, and we combined mass effects (as indexed by the lesion volume) with strategic strokes (as specifically predetermined). Hence, we developed a reproducible procedure for the accurate definition of small strategic strokes. We also used a comprehensive, standardized neuropsychological battery to explore all cognitive Global z score as a function of lesion volume (log scale) and the tertiles of total normalized brain volume. Linear relationship between the volume of stroke and the global cognitive score (GCS). The line of fit is shown with its 95% CI. Colored scatter plots represent the rough relationships between the value of total brain tissue volume (red tertile indicates a higher global cerebral atrophy than green and blue tertiles) and cognitive performance. The pale gray area corresponds to patients with low cognitive performance, small lesion volume (≤366 mm 3 ) , and without severe brain atrophy (tertiles 2 and 3 of the total brain tissue volume) and highlights the key role of strategic sites.
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domains (language, action speed, and executive function) and assessed cognitive performance after adjusting for demographic factors. Thus, the present results cannot be because of confusion between demographic factors and MRI determinants. Our study was not restricted to dementia or to the presence of cognitive impairment but also analyzed the cognitive score as a continuous variable; this reflects cognitive performance more accurately and is not affected by discretization errors. Optimized GCS and combined approach of both quantitative measures related to structure loss and qualitative measures related to the presence of strategic lesion are required to improve the determination of structure-function relationship and to study accurately cognition after stroke.
